CU Boulder researchers have developed a potent, drug-like compound that could someday revolutionize treatment of rheumatoid arthritis and other autoimmune diseases.
Days after Shalane Flanagan won the NYC Marathon, CU Boulder researchers have published a study that inspired the name of the shoes she wore and confirms they reduce the amount of energy used to run.
The research initiative will establish best practices and clinical infrastructure for advancing education on traumatic brain injury in student-athletes.
Faculty and students helped develop a plan for how to better represent indigenous histories and ongoing tribal relationships to the land that is now Rocky Mountain National Park.
Facebook, Twitter, and other social media platforms are becoming tools for tracking flu, Zika and other illnesses, signaling looming epidemics faster than public health agencies once could.
New CIRES research shows how a well-designed climate observing system could help scientists answer knotty questions about climate while delivering trillions of dollars in economic benefits.
The influenza A virus kills 12,000 to 56,000 people in the U.S. annually, but a newly discovered mechanism by which the human immune system tries to battle the virus could lead to new treatments.
With their brains, sleep patterns and eyes still developing, children and adolescents are particularly vulnerable to the sleep-disrupting effects of screen time. Watch a short video interview.
